Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy

Wentao Yang; Jianling Zou; Ye Li; Rujiao Liu; Zhengqing Yan; Shiqing Chen; Xiaoying Zhao; Weijian Guo; Mingzhu Huang; Wenhua Li; Xiaodong Zhu; Zhiyu Chen

doi:10.3389/fonc.2022.903586

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy

Front Oncol. 2022 May 11:12:903586. doi: 10.3389/fonc.2022.903586. eCollection 2022.

Authors

Wentao Yang^{1

2}, Jianling Zou^{1

2}, Ye Li^{2

3}, Rujiao Liu^{1

2}, Zhengqing Yan⁴, Shiqing Chen⁴, Xiaoying Zhao^{1

2}, Weijian Guo^{1

2}, Mingzhu Huang^{1

2}, Wenhua Li^{1

2}, Xiaodong Zhu^{1

2}, Zhiyu Chen^{1

2}

Affiliations

¹ Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
⁴ The Medical Department, 3D Medicines Inc., Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.830816.].

Keywords: circulating tumor DNA; colorectal cancer; dynamic monitoring; next-generation sequencing; prognosis.

Publication types

Published Erratum